"Maximum dose" points in cervical and endometrial cancer medium dose rate brachytherapy

被引:0
|
作者
Meysamie, A. [1 ]
Manshadi, H. R. Dehghan [2 ]
Sharafi, A. A. [3 ]
机构
[1] Univ Tehran Med Sci, Fac Med, Tehran, Iran
[2] Iran Univ Med Sci, Haft Tir Hosp, Tehran, Iran
[3] Iran Univ Med Sci, Dept Radiol Technol, Tehran, Iran
来源
关键词
RBrachytherapy; cervical & endometrial cancer; points of "maximum dose; dosimetry; COMPLICATION RATES; UTERINE CERVIX; CARCINOMA; DOSIMETRY;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background. Best dose distribution in target volume and control of Organ at Risk (OAR) dose are the two main goals in brachytherapy. Materials and Methods: In this study in vivo dosimetry in 4 rectal points was performed by Transillumination Dosimeter (TLD) s and the measured doses were compared in different patients. One point was reported to have the maximum dose in each patient and the very dose was considered as rectal dose according to ICRU-38 prescription; however, the next higher dose was also considered the same as the highest point when the difference was not more than 10% of the highest value. Results: In more than 50% of the cases the 1(st) and 2(nd) highest points were in the same range with less than 10% variation. There were 3 points in approximately equal dose in 7% of cases. Conclusion: These findings are challenging with the ICRU-38 recommendations reporting the existence of a sole maximum rectal dose. So it seems wise to consider an isodose plate of maximum doses instead of one point only. Iran. J. Radiat. Res., 2009; 6 (4): 189-194
引用
收藏
页码:189 / 194
页数:6
相关论文
共 50 条
  • [1] In vivo dosimetry with semiconductors in medium dose rate (MDR) brachytherapy for cervical cancer
    Mahmoud Allahverdi
    Ramin Jaberi
    Mehdi Aghili
    Fatemeh Ghahremani
    Ghazale Geraily
    Japanese Journal of Radiology, 2013, 31 : 160 - 165
  • [2] In vivo dosimetry with semiconductors in medium dose rate (MDR) brachytherapy for cervical cancer
    Allahverdi, Mahmoud
    Jaberi, Ramin
    Aghili, Mehdi
    Ghahremani, Fatemeh
    Geraily, Ghazale
    JAPANESE JOURNAL OF RADIOLOGY, 2013, 31 (03) : 160 - 165
  • [3] A Comparative Analysis of Different Prescription Points in High Dose Rate Brachytherapy of Cervical Cancer
    Kaur G.
    Srivastava A.K.
    Garg P.
    Kang M.S.
    Grover R.
    Gaur G.
    Sheetal S.
    Dangwal V.K.
    Iranian Journal of Medical Physics, 2022, 19 (04): : 234 - 240
  • [4] Sigmoid dose delivered by high-dose-rate brachytherapy versus low-dose-rate brachytherapy for cervical cancer
    Holloway, C. L.
    O'Farrell, D. A.
    Cormack, R. A.
    Viswanathan, A. N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S165 - S165
  • [5] High dose rate brachytherapy in the treatment of cervical cancer
    Petereit, DG
    VOLUME & KINETICS IN TUMOR CONTROL & NORMAL TISSUE COMPLICATIONS, 1998, : 148 - 170
  • [6] Fractionation in medium dose rate brachytherapy of cancer of the cervix
    Leborgne, F
    Fowler, JF
    Leborgne, JH
    Zubizarreta, E
    Chappell, R
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (05): : 907 - 914
  • [7] Pulsed-Dose Rate Brachytherapy for the Treatment of Endometrial Cancer
    De Felice, Francesca
    Caiazzo, Rossella
    Benevento, Ilaria
    Musio, Daniela
    Rubini, Filippo
    Tombolini, Vincenzo
    ONCOLOGY, 2017, 92 (06) : 311 - 316
  • [8] Dose rate correction in medium dose rate brachytherapy for carcinoma cervix
    Patel, FD
    Negi, PS
    Sharma, SC
    Kapoor, R
    Singh, DP
    Ghoshal, S
    RADIOTHERAPY AND ONCOLOGY, 1998, 49 (03) : 317 - 323
  • [9] Image guided high dose rate brachytherapy in cervical cancer
    Baird, V. E.
    Drake, A.
    Corrigan, K.
    Clarke, J.
    McGivern, U.
    Byrne, M.
    Workman, G.
    Farrell, R.
    CLINICAL ONCOLOGY, 2017, 29 : S5 - S5
  • [10] High dose rate vaginal brachytherapy in endometrial cancer after surgery
    Moreau-Claeys, M. -V.
    Brunaud, C.
    Hoffstetter, S.
    Buchheit, I.
    Peiffert, D.
    CANCER RADIOTHERAPIE, 2011, 15 (03): : 169 - 175